LEMAITRE VASCULAR, INC. (LMAT) Current Ratio
- Current ratio · latest quarter: Value 16.31×; Formula and calculation Current assets / current liabilities..
Current ratio
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Current ratio · latest quarter | 16.31× | Current assets / current liabilities. $488.30M ÷ $29.93M ≈ 16.31× |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Current assets | 488.30M USD | Assets, Current |
| Current obligations | 29.93M USD | Liabilities, Current |
| Cash and equivalents | 26.63M USD | Cash and Cash Equivalents, at Carrying Value |
| Short-term securities | 349.62M USD | Debt Securities, Available-for-sale, Current · Available-for-sale Securities, Current |
| Customer receivables | 35.68M USD | Accounts Receivable, after Allowance for Credit Loss, Current |
| Inventory | (m) | Inventory, Net |
| Payables | 3.24M USD | Accounts Payable, Current |
| Borrowing debt due within one year | (m) |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Current assets (USD) | Current obligations (USD) | Cash and equivalents (USD) | Short-term securities (USD) | Customer receivables (USD) | Inventory (USD) | Payables (USD) | Borrowing debt due within one year (USD) | Current ratio |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $488.30M | $29.93M | $26.63M | $349.62M | $35.68M | (m) | $3.24M | (m) | 16.31× |
| 2026-03-31 | $477.82M | $33.37M | $26.85M | $340.38M | $35.77M | (m) | $4.18M | (m) | 14.32× |
| 2025-12-31 | $468.23M | $36.32M | $28.24M | $330.88M | $33.61M | (m) | $3.65M | (m) | 12.89× |
| 2025-09-30 | $452.02M | $33.29M | $25.49M | $317.56M | $32.42M | (m) | $3.46M | (m) | 13.58× |
| 2025-06-30 | $430.13M | $30.82M | $27.18M | $292.31M | $36.54M | (m) | $4.91M | (m) | 13.96× |
| 2025-03-31 | $408.11M | $24.75M | $25.34M | $277.21M | $35.11M | (m) | $2.18M | (m) | 16.49× |
| 2024-12-31 | $402.19M | $30.61M | $25.61M | $274.11M | $30.06M | (m) | $1.76M | (m) | 13.14× |
| 2024-09-30 | $227.12M | $29.34M | $21.00M | $102.89M | $32.27M | (m) | $1.65M | (m) | 7.74× |
| 2024-06-30 | $212.81M | $25.45M | $22.27M | $90.83M | $30.82M | (m) | $2.00M | (m) | 8.36× |
| 2024-03-31 | $202.96M | $26.81M | $26.59M | $81.69M | $30.24M | (m) | $3.09M | (m) | 7.57× |
| 2023-12-31 | $194.60M | $29.88M | $24.27M | $80.81M | $25.06M | (m) | $3.73M | (m) | 6.51× |
| 2023-09-30 | $182.18M | $29.03M | $18.05M | $78.97M | $23.88M | (m) | $4.37M | (m) | 6.28× |
| 2023-06-30 | $174.49M | $25.86M | $19.49M | $70.69M | $26.41M | (m) | $3.52M | (m) | 6.75× |
| 2023-03-31 | $164.77M | $23.90M | $16.68M | $64.33M | $25.36M | (m) | $3.37M | (m) | 6.89× |
| 2022-12-31 | $161.73M | $25.33M | $19.13M | $63.56M | $22.04M | (m) | $2.90M | (m) | 6.39× |
| 2022-09-30 | $153.14M | $23.44M | $16.91M | $62.83M | $20.09M | (m) | $2.85M | (m) | 6.53× |
| 2022-06-30 | $148.49M | $23.41M | $20.79M | $54.90M | $21.54M | (m) | $2.84M | (m) | 6.34× |
| 2022-03-31 | $141.41M | $18.27M | $15.56M | $55.32M | $21.39M | (m) | $2.19M | (m) | 7.74× |
| 2021-12-31 | $139.88M | $21.81M | $13.86M | $56.10M | $19.63M | (m) | $2.34M | (m) | 6.41× |
| 2021-09-30 | $134.02M | $22.11M | $17.37M | $49.71M | $19.50M | (m) | $3.14M | (m) | 6.06× |
| 2021-06-30 | $90.02M | $21.48M | $21.54M | $215.00K | $20.74M | (m) | $2.06M | (m) | 4.19× |
| 2021-03-31 | $90.66M | $22.30M | $23.52M | $214.00K | $20.13M | (m) | $2.56M | (m) | 4.07× |
| 2020-12-31 | $94.26M | $25.14M | $26.76M | $214.00K | $19.55M | (m) | $2.39M | (m) | 3.75× |
| 2020-09-30 | $102.25M | $44.45M | $29.28M | $5.10M | $19.63M | (m) | $2.17M | (m) | 2.30× |
| 2020-06-30 | $91.87M | $44.36M | $19.98M | $5.07M | $17.70M | (m) | $1.24M | (m) | 2.07× |
| 2020-03-31 | $89.72M | $16.59M | $10.94M | $19.69M | $16.63M | (m) | $1.38M | (m) | 5.41× |
| 2019-12-31 | $92.09M | $20.85M | $11.79M | $20.89M | $16.57M | (m) | $2.60M | (m) | 4.42× |
| 2019-09-30 | $99.69M | $19.32M | $11.72M | $33.18M | $14.88M | (m) | $1.67M | (m) | 5.16× |
| 2019-06-30 | $98.16M | $17.42M | $13.26M | $34.98M | $15.55M | (m) | $1.43M | (m) | 5.63× |
| 2019-03-31 | $95.42M | $19.39M | $14.77M | $32.69M | $15.46M | (m) | $2.38M | (m) | 4.92× |
| 2018-12-31 | $94.02M | $19.76M | $26.32M | $21.67M | $15.72M | (m) | $1.73M | (m) | 4.76× |
| 2018-09-30 | $86.81M | $14.64M | $20.10M | $25.52M | $13.02M | (m) | $1.63M | (m) | 5.93× |
| 2018-06-30 | $92.36M | $13.12M | $19.64M | $33.30M | $15.23M | (m) | $1.66M | (m) | 7.04× |
| 2018-03-31 | $84.01M | $12.64M | $22.78M | $22.61M | $14.51M | (m) | $1.44M | (m) | 6.65× |
| 2017-12-31 | $80.31M | $13.19M | $19.10M | $22.56M | $15.00M | (m) | $1.54M | (m) | 6.09× |
| 2017-09-30 | $75.64M | $12.11M | $37.51M | (m) | $13.55M | (m) | $1.62M | (m) | 6.25× |
| 2017-06-30 | $68.09M | $9.40M | $30.12M | (m) | $14.59M | $20.46M | $1.57M | (m) | 7.25× |
| 2017-03-31 | $62.50M | $10.77M | $25.81M | (m) | $14.09M | $20.60M | $2.22M | (m) | 5.81× |
| 2016-12-31 | $59.03M | $10.48M | $24.29M | (m) | $13.19M | (m) | $1.22M | (m) | 5.63× |
| 2016-09-30 | $68.23M | $12.06M | $34.65M | (m) | $12.18M | $17.43M | $1.15M | (m) | 5.66× |
| 2016-06-30 | $62.42M | $10.14M | $29.32M | (m) | $12.84M | $16.96M | $1.55M | (m) | 6.16× |
| 2016-03-31 | $59.74M | $10.16M | $25.94M | (m) | $13.02M | $17.90M | $1.77M | (m) | 5.88× |
| 2015-12-31 | $58.18M | $10.37M | $27.45M | (m) | $11.97M | $15.21M | $1.37M | (m) | 5.61× |
| 2015-09-30 | $53.98M | $8.83M | $23.63M | (m) | $11.34M | $15.92M | $931.00K | (m) | 6.11× |
| 2015-06-30 | $50.31M | $9.24M | $19.43M | (m) | $12.24M | $15.78M | $1.29M | (m) | 5.45× |
| 2015-03-31 | $47.80M | $8.39M | $17.02M | (m) | $11.88M | $16.46M | $1.13M | (m) | 5.70× |
| 2014-12-31 | $48.59M | $10.04M | $18.69M | (m) | $10.80M | $16.71M | $1.13M | (m) | 4.84× |
| 2014-09-30 | $49.43M | $12.58M | $18.35M | (m) | $10.59M | $16.93M | $1.02M | (m) | 3.93× |
| 2014-06-30 | $53.00M | $9.01M | $23.51M | (m) | $11.37M | $14.99M | $1.02M | (m) | 5.88× |
| 2014-03-31 | $40.34M | $8.71M | $12.50M | (m) | $10.49M | $14.19M | $1.04M | (m) | 4.63× |
| 2013-12-31 | $41.73M | $10.22M | $14.71M | (m) | $10.59M | $13.26M | $1.24M | (m) | 4.08× |
| 2013-09-30 | $39.04M | $9.29M | $13.63M | (m) | $9.27M | $13.08M | $748.00K | (m) | 4.20× |
| 2013-06-30 | $38.84M | $7.46M | $14.91M | (m) | $9.71M | $11.65M | $1.01M | (m) | 5.21× |
| 2013-03-31 | $38.73M | $7.87M | $15.30M | (m) | $9.36M | $11.27M | $929.00K | (m) | 4.92× |
| 2012-12-31 | $39.13M | $8.39M | $16.45M | (m) | $9.05M | $10.86M | $1.06M | (m) | 4.66× |
| 2012-09-30 | $42.19M | $8.20M | $20.64M | (m) | $8.47M | $10.13M | $879.00K | (m) | 5.15× |
| 2012-06-30 | $40.67M | $6.94M | $20.16M | (m) | $8.80M | $9.13M | $937.00K | (m) | 5.86× |
| 2012-03-31 | $39.62M | $6.29M | $19.62M | (m) | $8.69M | $8.30M | $825.00K | (m) | 6.30× |
| 2011-12-31 | $39.69M | $6.54M | $20.13M | (m) | $8.54M | $8.00M | $981.00K | (m) | 6.07× |
| 2011-09-30 | $42.89M | $9.86M | $23.09M | (m) | $8.85M | $7.25M | $1.28M | (m) | 4.35× |
| 2011-06-30 | $41.62M | $8.36M | $21.41M | (m) | $9.07M | $7.81M | $1.20M | (m) | 4.98× |
| 2010-12-31 | $42.91M | $10.39M | $22.61M | (m) | $8.47M | $8.38M | $1.32M | (m) | 4.13× |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NovoCure Ltd (NVCR) | $1.886B | -11.87 | |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |